| Lauren Bakaletz, PhD | 06/01/07-05/31/09 | GlaxoSmith Kline TRINCH563388 |
| Identification and Assessment of Several Targeted and Novel Candidate Antigens for the Prevention of NTHI- Induced Otitis Media | ||
| Abraham Jacob, MD | 08/15/08-08/14/09 | Triological Society |
| Combination EGFR and AKT Pathway Inhibition for Treating Vestibular Schwannoma | ||
| Jas Lang, PhD | 7/01/06-6/31/09 | State of Ohio Biomedic Research and Commercialization |
| Devices for Disease Diagnosis and Therapy | ||
| Quintin Pan, PhD | 07/01/08-06/30/11 | Flight Attendant Med. Res. Inst. GRT00013551 |
| Development of PK-Cepsilon Inhibitors for Treating Head and Neck Cancer | ||
| Quintin Pan, PhD | 07/01/08-06/30/12 | American Cancer Society |
| Mechanism of PKC-Induced Tumorigenesis in Head and Neck Cancer | ||
| Theodoros Teknos, MD | 2008-2013 | SPORE, Project 1 |
| Metronomic Small Molecular Inhibitor of Bcl-2 in Head and Neck Cancer Therapy | ||
| Christopher Weghorst, PhD Amit Agrawal, MD |
07/01/06-06/30/11 | American Cancer Society |
| Chemoprevention of Oral Cancer in Appalachia | ||
